Ruth Atzmon
About
Ruth Atzmon is a scholar working on Molecular Biology, Cell Biology and Cancer Research.
According to data from OpenAlex, Ruth Atzmon has authored 23 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Cell Biology and 4 papers in Cancer Research. Recurrent topics in Ruth Atzmon's work include Proteoglycans and glycosaminoglycans research (13 papers), Glycosylation and Glycoproteins Research (8 papers) and Fibroblast Growth Factor Research (5 papers). Ruth Atzmon is often cited by papers focused on Proteoglycans and glycosaminoglycans research (13 papers), Glycosylation and Glycoproteins Research (8 papers) and Fibroblast Growth Factor Research (5 papers). Ruth Atzmon collaborates with scholars based in Israel, United States and Sweden. Ruth Atzmon's co-authors include Israël Vlodavsky, Michael Elkin, Yael Friedmann, Tamar Peretz, Helena Aingorn, Rivka Ishai-Michaeli, Zvi Fuks, Iris Pecker, Orit Pappo and Menachem Bitan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.
In The Last Decade
Ruth Atzmon
23 papers receiving 2.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ruth Atzmon Israel | 20 | 1.5k | 1.4k | 280 | 272 | 238 | 23 | 2.2k | ||
| Helena Aingorn Israel | 17 | 1.4k 1.0× | 1.5k 1.1× | 179 0.6× | 279 1.0× | 260 1.1× | 19 | 2.0k | ||
| Gudrun Bäckström Sweden | 14 | 1.3k 0.9× | 863 0.6× | 333 1.2× | 257 0.9× | 250 1.1× | 18 | 2.1k | ||
| Josette Badet France | 22 | 896 0.6× | 233 0.2× | 213 0.8× | 195 0.7× | 62 0.3× | 49 | 1.5k | ||
| Hans‐Georg Wisniewski United States | 22 | 724 0.5× | 623 0.4× | 165 0.6× | 97 0.4× | 41 0.2× | 33 | 1.8k | ||
| Kleinman Hk United States | 6 | 1.0k 0.7× | 359 0.3× | 574 2.0× | 120 0.4× | 53 0.2× | 8 | 2.1k | ||
| Martin Gr United States | 12 | 1.1k 0.8× | 402 0.3× | 624 2.2× | 126 0.5× | 55 0.2× | 21 | 2.4k | ||
| Alan Horner United Kingdom | 15 | 780 0.5× | 278 0.2× | 204 0.7× | 108 0.4× | 46 0.2× | 32 | 1.5k | ||
| Atsushi Kon Japan | 20 | 783 0.5× | 623 0.4× | 156 0.6× | 31 0.1× | 96 0.4× | 43 | 1.3k | ||
| Stephanie Taylor United States | 8 | 674 0.5× | 281 0.2× | 261 0.9× | 100 0.4× | 44 0.2× | 12 | 1.2k | ||
| Thomas C. Wright United States | 15 | 619 0.4× | 482 0.3× | 222 0.8× | 97 0.4× | 26 0.1× | 26 | 1.3k |
Countries citing papers authored by Ruth Atzmon
Since
Specialization
Citations
This map shows the geographic impact of Ruth Atzmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Atzmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Atzmon more than expected).
Fields of papers citing papers by Ruth Atzmon
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ruth Atzmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Atzmon. The network helps show where Ruth Atzmon may publish in the future.
Co-authorship network of co-authors of Ruth Atzmon
This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Atzmon. A scholar is included among the top collaborators of Ruth Atzmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Atzmon. Ruth Atzmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Goldberg, Rachel, Ariel M. Rubinstein, Esther Hermano, et al.. (2014). Role of Heparanase-Driven Inflammatory Cascade in Pathogenesis of Diabetic Nephropathy. Diabetes. 63(12). 4302–4313.
2.
Zcharia, Eyal, Ruth Atzmon, Adi Nagler, et al.. (2012). Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor. Anti-Cancer Drugs. 23(10). 1022–1031.
3.
Lerner, Immanuel, Esther Hermano, Eyal Zcharia, et al.. (2011). Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. Journal of Clinical Investigation. 121(5). 1709–1721.
4.
Abboud-Jarrous, Ghada, Ruth Atzmon, Tamar Peretz, et al.. (2008). Cathepsin L Is Responsible for Processing and Activation of Proheparanase through Multiple Cleavages of a Linker Segment. Journal of Biological Chemistry. 283(26). 18167–18176.
5.
Abboud-Jarrous, Ghada, Helena Aingorn, Ruth Atzmon, et al.. (2005). Site-directed Mutagenesis, Proteolytic Cleavage, and Activation of Human Proheparanase. Journal of Biological Chemistry. 280(14). 13568–13575.
6.
Atzmon, Ruth, et al.. (2005). Heparanase processing by lysosomal/endosomal protein preparation. FEBS Letters. 579(11). 2334–2338.
7.
Vlodavsky, Israël, Orit Goldshmidt, Eyal Zcharia, et al.. (2002). Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Seminars in Cancer Biology. 12(2). 121–129.
8.
Vlodavsky, Israël, Orit Goldshmidt, Eyal Zcharia, et al.. (2001). Molecular properties and involvement of heparanase in cancer progression and normal development. Biochimie. 83(8). 831–839.
9.
Goldshmidt, Orit, Eyal Zcharia, Helena Aingorn, et al.. (2001). Expression Pattern and Secretion of Human and Chicken Heparanase Are Determined by Their Signal Peptide Sequence. Journal of Biological Chemistry. 276(31). 29178–29187.
10.
Vlodavsky, Israël, Orit Pappo, Helena Aingorn, et al.. (2000). Mammalian heparanase as mediator of tumor metastasis and angiogenesis.. PubMed. 2 Suppl. 37–45.
11.
Vlodavsky, Israël, Yael Friedmann, Michael Elkin, et al.. (1999). Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis. Nature Medicine. 5(7). 793–802.
12.
Hosokawa, Kumiko, Dorit Aharoni, Ada Dantes, et al.. (1998). Modulation of Mdm2 Expression and p53-Induced Apoptosis in Immortalized Human Ovarian Granulosa Cells**This work was supported by grants from the Israel Academy of Sciences (to I.V. and A.A.), by the Israeli Ministry of Science (to A.A.), by the Leo and Julia Forchheimer Center of Molecular Genetics at the Weizmann Institute of Science (to A.A.) and by a Grant-in-Aid 0704424 from the Ministry of Education, Science and Culture of Japan (to F.K., K.H., and A.A.).. Endocrinology. 139(11). 4688–4700.
13.
Aharoni, Dorit, Iris Meiri, Ruth Atzmon, Israël Vlodavsky, & Abraham Amsterdam. (1997). Differential effect of components of the extracellular matrix on differentiation and apoptosis. Current Biology. 7(1). 43–51.
14.
Miao, Hua‐Quan, Rivka Ishai-Michaeli, Ruth Atzmon, Tamar Peretz, & Israël Vlodavsky. (1996). Sulfate Moieties in the Subendothelial Extracellular Matrix Are Involved in Basic Fibroblast Growth Factor Sequestration, Dimerization, and Stimulation of Cell Proliferation. Journal of Biological Chemistry. 271(9). 4879–4886.
15.
Vlodavsky, Israël, Hua‐Quan Miao, Ruth Atzmon, et al.. (1995). Control of Cell Proliferation by Heparan Sulfate and Heparin-Binding Growth Factors. Thrombosis and Haemostasis. 74(1). 534–540.
16.
Rogelj, Snezna, Michael Klagsbrun, Ruth Atzmon, et al.. (1989). Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells.. The Journal of Cell Biology. 109(2). 823–831.
17.
Atzmon, Ruth, Ezra Rahamim, Rachel Bar‐Shavit, et al.. (1988). STRIATED MUSCLE FIBERS DIFFERENTIATE IN PRIMARY CULTURES OF ADULT ANTERIOR PITUITARY CELLS. Endocrinology. 122(6). 3002–3004.
18.
Vlodavsky, Israël, Rina Ulmansky, Ruth Atzmon, et al.. (1983). Thyrotrophin and growth hormone secretion and cell morphology in hypothyroid pituitary cells cultured on a natural extracellular matrix. European Journal of Endocrinology. 104(3). 279–286.
19.
Vlodavsky, Israël, Amiram Eldor, Esti Hyam, Ruth Atzmon, & Zvi Fuks. (1982). Platelet interaction with the extracellular matrix produced by cultured endothelial cells: A model to study the thrombogenicity of isolated subendothelial basal lamina. Thrombosis Research. 28(2). 179–191.
20.
Vlodavsky, Israël, Yafa Ariav, Ruth Atzmon, & Zvi Fuks. (1982). Tumor cell attachment to the vascular endothelium and subsequent degradation of the subendothelial extracellular matrix. Experimental Cell Research. 140(1). 149–159.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Helena Aingorn Breakdown of academic impact, for papers by Gudrun Bäckström Breakdown of academic impact, for papers by Josette Badet Breakdown of academic impact, for papers by Hans‐Georg Wisniewski Breakdown of academic impact, for papers by Kleinman Hk Breakdown of academic impact, for papers by Martin Gr Breakdown of academic impact, for papers by Alan Horner Breakdown of academic impact, for papers by Atsushi Kon Breakdown of academic impact, for papers by Stephanie Taylor Breakdown of academic impact, for papers by Thomas C. Wright